Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The Best- And Worst-Performing Biotech Stocks In February
The Best- And Worst-Performing Biotech Stocks In February
The Best- And Worst-Performing Biotech Stocks In February
Submitted by
admin
on March 4, 2013 - 10:55am
Source:
Forbes
News Tags:
Optimer
Questcor
Celldex
OraSure
Pharmacyclics
Taro
Synta Pharmaceuticals
Keryx
Dynavax
Affymax
Headline:
The Best- And Worst-Performing Biotech Stocks In February
Do Not Allow Advertisers to Use My Personal information
